| Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase … D Marin, AR Ibrahim, C Lucas, G Gerrard, L Wang, RM Szydlo, RE Clark, ... Journal of Clinical Oncology 30 (3), 232, 2012 | 594 | 2012 |
| European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor D Marin, D Milojkovic, E Olavarria, JS Khorashad, H De Lavallade, ... Blood, The Journal of the American Society of Hematology 112 (12), 4437-4444, 2008 | 413 | 2008 |
| Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia K Stringaris, T Sekine, A Khoder, A Alsuliman, B Razzaghi, R Sargeant, ... haematologica 99 (5), 836, 2014 | 218 | 2014 |
| Treatment and management of graft-versus-host disease: improving response and survival C Garnett, JF Apperley, J Pavlů Therapeutic advances in hematology 4 (6), 366-378, 2013 | 217 | 2013 |
| Three decades of transplantation for chronic myeloid leukemia: what have we learned? J Pavlů, RM Szydlo, JM Goldman, JF Apperley Blood, The Journal of the American Society of Hematology 117 (3), 755-763, 2011 | 174 | 2011 |
| Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation A Chaidos, S Patterson, R Szydlo, MS Chaudhry, F Dazzi, E Kanfer, ... Blood, The Journal of the American Society of Hematology 119 (21), 5030-5036, 2012 | 170 | 2012 |
| Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host H de Lavallade, P Garland, T Sekine, K Hoschler, D Marin, K Stringaris, ... Haematologica 96 (2), 307, 2011 | 149 | 2011 |
| Augmented reduced-intensity regimen does not improve postallogeneic transplant outcomes in acute myeloid leukemia C Craddock, A Jackson, J Loke, S Siddique, A Hodgkinson, J Mason, ... Journal of Clinical Oncology 39 (7), 768, 2021 | 111 | 2021 |
| The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants A Rio-Machin, T Vulliamy, N Hug, A Walne, K Tawana, S Cardoso, ... Nature communications 11 (1), 1044, 2020 | 93 | 2020 |
| Optimizing patient selection for myeloablative allogeneic hematopoietic cell transplantation in chronic myeloid leukemia in chronic phase J Pavlů, AK Kew, B Taylor-Roberts, HW Auner, D Marin, E Olavarria, ... Blood, The Journal of the American Society of Hematology 115 (20), 4018-4020, 2010 | 73 | 2010 |
| Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the … J Pavlů, M Labopin, R Niittyvuopio, G Socié, I Yakoub-Agha, D Wu, ... Journal of hematology & oncology 12, 1-9, 2019 | 62 | 2019 |
| Superwarfarin poisoning J Pavlu, DJ Harrington, K Voong, GF Savidge, R Jan-Mohamed, ... The Lancet 365 (9459), 628, 2005 | 58 | 2005 |
| Disease prevention not decolonization: a model for fecal microbiota transplantation in patients colonized with multidrug-resistant organisms R Ghani, BH Mullish, JAK McDonald, A Ghazy, HRT Williams, ... Clinical Infectious Diseases 72 (8), 1444-1447, 2021 | 55 | 2021 |
| Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation HW Auner, R Szydlo, A Rone, A Chaidos, C Giles, E Kanfer, ... Leukemia & lymphoma 54 (10), 2200-2204, 2013 | 53 | 2013 |
| Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies J Beckerson, RM Szydlo, M Hickson, CE Mactier, AJ Innes, IH Gabriel, ... Clinical nutrition 38 (2), 738-744, 2019 | 51 | 2019 |
| BKV‐specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA‐haploidentical haematopoietic cell transplantation OM Pello, AJ Innes, A Bradshaw, SA Finn, S Uddin, E Bray, E Olavarria, ... European Journal of Haematology 98 (6), 632-634, 2017 | 51 | 2017 |
| Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: a report from the Acute Leukemia Working Party of the EBMT J Pavlů, M Labopin, AK Zoellner, I Sakellari, M Stelljes, J Finke, R Fanin, ... Cancer 123 (11), 1965-1970, 2017 | 38 | 2017 |
| Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia A Nagler, B Dholaria, M Labopin, BN Savani, E Angelucci, Y Koc, M Arat, ... Leukemia 34 (10), 2766-2775, 2020 | 36 | 2020 |
| Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality AJ Innes, BH Mullish, F Fernando, G Adams, JR Marchesi, JF Apperley, ... Bone marrow transplantation 52 (10), 1452-1454, 2017 | 34 | 2017 |
| EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedure K Rezvani, EJ Kanfer, D Marin, I Gabriel, A Rahemtulla, A Taylor, ... Biology of Blood and Marrow Transplantation 18 (2), 235-240, 2012 | 31 | 2012 |
